Michael Gottschalk, M.D., Ph.D.




Rady Children's Specialists of San Diego

Medical Group / IPA

Rady Children's Specialists

Medical School

Chicago Medical School


University of California Los Angeles


University of California Los Angeles

Board Certifications

Pediatric Endocrinology, Pediatrics




Dr. Michael Gottschalk is chief of the Endocrinology/Diabetes Division at Rady Children's Hospital-San Diego and a clinical professor at UC San Diego School of Medicine.

Graduating from Holy Cross College, he went on to attend the University of Health Sciences/The Chicago Medical School, where he earned a Ph.D. in biochemistry, graduated with honors and was a member of the Alpha Omega Alpha Honor Society. Upon completing his pediatric residency and a pediatric endocrinology fellowship at the University of California, Los Angeles, he joined the faculty at Loyola University in Chicago. In 1996, he moved to San Diego.

Dr. Gottschalk treats children and adolescents with a wide range of endocrine disorders and diabetes mellitus. He continues to focus time on various research pursuits, including growth hormone treatments and type 1 and 2 diabetes mellitus.


Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial
Gitelman SE, Gottlieb PA, Felner EI, Willi SM, Fisher LK, Moran A, Gottschalk M, Moore WV, Pinckney A, Keyes-Elstein L, Harris KM, Kanaparthi S, Phippard D, Ding L, Bluestone JA, Ehlers MR; ITN START Study Team

Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial
Libman IM, Miller KM, DiMeglio LA, Bethin KE, Katz ML, Shah A, Simmons JH, Haller MJ, Raman S, Tamborlane WV, Coffey JK, Saenz AM, Beck RW, Nadeau KJ; T1D Exchange Clinic Network Metformin RCT Study Group

Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States
DuBose SN, Hermann JM, Tamborlane WV, Beck RW, Dost A, DiMeglio LA, Schwab KO, Holl RW, Hofer SE, Maahs DM; Type 1 Diabetes Exchange Clinic Network and Diabetes Prospective Follow-up Registry

Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial
Backeljauw PF, Miller BS, Dutailly P, Houchard A, Lawson E, Hale DE, Reiner B, Sperling MA; MS316 Study Group

Racial-ethnic disparities in management and outcomes among children with type 1 diabetes
Willi SM, Miller KM, DiMeglio LA, Klingensmith GJ, Simmons JH, Tamborlane WV, Nadeau KJ, Kittelsrud JM, Huckfeldt P, Beck RW, Lipman TH; T1D Exchange Clinic Network

Successful use of long acting octreotide in two cases with Beckwith-Wiedemann syndrome and severe hypoglycemia
Al-Zubeidi H, Gottschalk ME, Newfield RS

Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial
Griffin KJ, Thompson PA, Gottschalk M, Kyllo JH, Rabinovitch A

Influence of specific individual and environmental variables on the relationship between body mass index and health-related quality of life in overweight and obese adolescents
Kolodziejczyk JK, Gutzmer K, Wright SM, Arredondo EM, Hill L, Patrick K, Huang JS, Gottschalk M, Norman GJ

Preparing adolescents with chronic disease for transition to adult care: a technology program
Huang JS, Terrones L, Tompane T, Dillon L, Pian M, Gottschalk M, Norman GJ, Bartholomew LK

Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia
Lim YH, Ovejero D, Sugarman JS, Deklotz CM, Maruri A, Eichenfield LF, Kelley PK, Juppner H, Gottschalk M, Tifft CJ, Gafni RI, Boyce AM, Cowen EW, Bhattacharyya N, Guthrie LC, Gahl WA, Golas G, Loring EC, Overton JD, Mane SM, Lifton RP, Levy ML, Collins MT, Choate KA

Outcomes of a 12-month technology-based intervention to promote weight loss in adolescents at risk for type 2 diabetes
Patrick K, Norman GJ, Davila EP, Calfas KJ, Raab F, Gottschalk M, Sallis JF, Godbole S, Covin JR

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
Gitelman SE, Gottlieb PA, Rigby MR, Felner EI, Willi SM, Fisher LK, Moran A, Gottschalk M, Moore WV, Pinckney A, Keyes-Elstein L, Aggarwal S, Phippard D, Sayre PH, Ding L, Bluestone JA, Ehlers MR; START Study Team

Efficacy of IGF-based growth hormone (GH) dosing in nonGH-deficient (nonGHD) short stature children with low IGF-I is not related to basal IGF-I levels
Cohen P, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG, Germak J; American Norditropin Study Group

The T1D Exchange clinic registry
Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA; T1D Exchange Clinic Network

Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
Krone N, Reisch N, Idkowiak J, Dhir V, Ivison HE, Hughes BA, Rose IT, O'Neil DM, Vijzelaar R, Smith MJ, MacDonald F, Cole TR, Adolphs N, Barton JS, Blair EM, Braddock SR, Collins F, Cragun DL, Dattani MT, Day R, Dougan S, Feist M, Gottschalk ME, Gregory JW, Haim M, Harrison R, Olney AH, Hauffa BP, Hindmarsh PC, Hopkin RJ, Jira PE, Kempers M, Kerstens MN, Khalifa MM, Kohler B, Maiter D, Nielsen S, O'Riordan SM, Roth CL, Shane KP, Silink M, Stikkelbroeck NM, Sweeney E, Szarras-Czapnik M, Waterson JR, Williamson L, Hartmann MF, Taylor NF, Wudy SA, Malunowicz EM, Shackleton CH, Arlt W

Transition to adult care: systematic assessment of adolescents with chronic illnesses and their medical teams
Huang JS, Gottschalk M, Pian M, Dillon L, Barajas D, Bartholomew LK

Insulin infusion to treat severe hypertriglyceridemia associated with pegaspargase therapy: a case report
Lawson EB, Gottschalk M, Schiff DE

Compliance with behavioral guidelines for diet, physical activity and sedentary behaviors is related to insulin resistance among overweight and obese youth
Huang JS, Gottschalk M, Norman GJ, Calfas KJ, Sallis JF, Patrick K

Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial
Midyett LK, Rogol AD, Van Meter QL, Frane J, Bright GM; MS301 Study Group

Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children
Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG; American Norditropin Study Group

Relation of body fat indexes to vitamin D status and deficiency among obese adolescents
Lenders CM, Feldman HA, Von Scheven E, Merewood A, Sweeney C, Wilson DM, Lee PD, Abrams SH, Gitelman SE, Wertz MS, Klish WJ, Taylor GA, Chen TC, Holick MF; Elizabeth Glaser Pediatric Research Network Obesity Study Group

Ethnic origin is unrelated to autoimmunity and residual pancreatic function in 471 youth with clinically diagnosed type 2 diabetes
Gottschalk M, Danne T, Fuerst-Recktenwald S

Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover study
Malloy J, Capparelli E, Gottschalk M, Guan X, Kothare P, Fineman M

Autoimmune thyroiditis and acquired hypothyroidism in an infant with severe combined immunodeficiency due to adenosine deaminase deficiency
Nagpala P, Newfield R, Bastian J, Gottschalk M

Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study
Gottschalk M, Danne T, Vlajnic A, Cara JF

PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.